Lung Ischemia-Reperfusion Injury in Lung Transplant Surgery: Where Do We Stand?

Antioxidants (Basel) · 2025 · PMC12649343 · PMID 41300452

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

These promising results have led to a recent blinded multicenter randomized controlled trial of regadenoson, an A2A agonist, in lung transplant patients, recently showed a trend towards reducing IRI [ 222 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.